A Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Patients With Squamous Cell Carcinoma of the Lung
Status:
Completed
Trial end date:
2015-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this Phase 2 study is to investigate whether intravenous administration of
REOLYSIN therapeutic reovirus in combination with paclitaxel and carboplatin is effective and
safe in the treatment of squamous cell carinoma of the lung.